Goodwin Matthew L, Loomans Janneke I, Barzilai Ori, Dea Nicolas, Gasbarrini Alessandro, Lazáry Aron, Netzer Cordula, Reynolds Jeremy, Rhines Laurence, Sahgal Arjun, Verlaan Jorrit-Jan, Fisher Charles G, Laufer Ilya
Washington University School of Medicine, St. Louis, MO, USA.
AO Foundation, Davos Platz, Switzerland.
Global Spine J. 2025 Jun;15(5):2754-2766. doi: 10.1177/21925682251314497. Epub 2025 Jan 27.
Study Designcross-sectional survey.ObjectivesTo evaluate AO Spine members' practices and comfort in managing metastatic and primary spine tumors, explore the use of decision-support and patient assessment tools, and identify knowledge gaps and future needs in spine oncology.MethodsAn online survey was distributed to AO Spine members to query comfort levels with key decisions in spinal oncology management, utilization of decision frameworks and spine oncology-specific instruments, and educational material preferences.ResultsResponses were obtained from 381 members across 82 countries. Most respondents were orthopedic spine surgeons (62%) or neurosurgeons (36%), with 42% performing 100-200 spine surgeries per year. Extradural primary and metastatic tumors were managed by 84% and 95% of respondents, respectively, with survival and frailty assessment tools used for both. While most surgeons felt comfortable determining when emergency surgery was needed (81% for primary and 82% for metastatic tumors), nuanced decisions about surgical timing were more challenging. Surgeons also noted challenges in tailoring the oncologic surgical plan to what the patient could safely tolerate. There was a strong desire for guidelines on tumor-related spinal pain (85%), treatment timing (85%), stabilization (85%), and glucocorticoid use for symptomatic extradural metastatic tumors (77%). Interest was high for classification systems for spine tumor pain (65%) and stabilization decisions (80%).ConclusionsAdditional support is needed in decision-making regarding surgical timing, patient selection, and tailoring treatment invasiveness to life expectancy and frailty. Surgeons seek further guidance to prevent neurologic deterioration and optimize recovery. Guidelines and classification systems were highly coveted for daily practice.
横断面调查。
评估AO脊柱学会成员在处理转移性和原发性脊柱肿瘤方面的实践和舒适度,探索决策支持和患者评估工具的使用情况,并确定脊柱肿瘤学方面的知识差距和未来需求。
向AO脊柱学会成员发放在线调查问卷,询问他们在脊柱肿瘤学管理关键决策方面的舒适度、决策框架和脊柱肿瘤专用工具的使用情况以及教育材料偏好。
来自82个国家的381名成员回复了问卷。大多数受访者是脊柱骨科医生(62%)或神经外科医生(36%),42%的人每年进行100 - 200例脊柱手术。分别有84%和95%的受访者处理硬脊膜外原发性和转移性肿瘤,两者均使用生存和虚弱评估工具。虽然大多数外科医生对确定何时需要急诊手术感到得心应手(原发性肿瘤为81%,转移性肿瘤为82%),但关于手术时机的细微决策更具挑战性。外科医生还指出,根据患者能够安全耐受的情况制定肿瘤外科手术计划也存在挑战。对于肿瘤相关脊柱疼痛(85%)、治疗时机(85%)、稳定化(85%)以及有症状的硬脊膜外转移性肿瘤使用糖皮质激素(77%)方面的指南有强烈需求。对脊柱肿瘤疼痛分类系统(65%)和稳定化决策(80%)的兴趣也很高。
在手术时机、患者选择以及根据预期寿命和虚弱程度调整治疗侵入性等决策方面需要更多支持。外科医生寻求进一步指导以防止神经功能恶化并优化恢复。指南和分类系统在日常实践中备受期待。